Windlas Biotech Completes Extinguishment of 4,70,000 Equity Shares Under Buyback

Windlas Biotech Limited has completed the extinguishment of 4,70,000 (Four Lakh Seventy Thousand) fully paid-up equity shares of face value INR 5 each on May 18, 2026, marking the final step in its share buyback programme. The extinguishment was carried out in dematerialised form through National Securities Depository Limited (NSDL), with confirmation received on May 18, 2026. No equity shares were tendered or extinguished in physical form. The completion follows the buyback's tendering period, which ran from April 30, 2026 to May 07, 2026, during which the company repurchased shares at INR 1,000 per equity share through the tender offer route, utilising a total amount of INR 47,00,00,000 (Indian Rupees Forty Seven Crore Only), excluding transaction costs.

Buyback Programme Overview

The Board of Directors approved the buyback at its meeting on April 17, 2026. The Public Announcement was dated April 18, 2026 and published on April 20, 2026, followed by the Letter of Offer dated April 27, 2026 and the Offer Opening Advertisement dated April 28, 2026, published on April 29, 2026. The Record Date for determining eligible shareholders was April 24, 2026, and BSE served as the designated stock exchange. The buyback represented 2.23% of the total equity shares in the existing total paid-up equity share capital, and the Buyback Offer Size represented 9.80% of the aggregate of the total paid-up equity share capital and free reserves (including securities premium) based on the latest audited standalone and consolidated financial statements as at March 31, 2025.

Parameter: Details Buyback Price: INR 1,000 per equity share Total Shares Bought Back: 4,70,000 equity shares Total Amount Utilised: INR 47,00,00,000 (excl. transaction costs) Face Value per Share: INR 5.00 % of Total Paid-up Capital: 2.23% Buyback Offer Size (% of capital & reserves): 9.80% (standalone and consolidated) Record Date: April 24, 2026 Tendering Period: April 30, 2026 – May 07, 2026 Designated Stock Exchange: BSE Date of Extinguishment: May 18, 2026

Share Capital Reconciliation Post Extinguishment

With the extinguishment now complete, the company's paid-up equity share capital has been formally reduced. The table below presents the reconciliation of share capital before and after the buyback:

Sr. No.: Particulars: No. of Equity Shares: Equity Share Capital (In INR): 1. Paid-up equity share capital (Pre-Buyback) 2,11,06,229 10,55,31,145 2. Less: Total Equity Shares (Demat) extinguished 4,70,000 23,50,000 3. Less: Total Equity Shares (Physical) extinguished — — 4. Paid-up equity share capital (Post Buyback) 2,06,36,229 10,31,81,145

The extinguishment was executed through SMC Global Securities Limited (DP ID: IN303655) as the Depository Participant, with NSDL as the depository and Company Client ID No. 10340791. The NSDL confirmation letter dated May 18, 2026 confirmed the debit of 4,70,000 equity shares (ISIN: INE0H5O01029) with an execution date of May 16, 2026.

Bid Response and Settlement

The buyback received strong investor interest. MUFG Intime India Private Limited, the Registrar to the Buyback, considered a total of 9,857 valid bids for 26,57,484 (Twenty Six Lakh Fifty Seven Thousand Four Hundred Eighty Four) equity shares, representing approximately 5.65 times the maximum number of equity shares proposed to be bought back. The following table details the category-wise bid response:

Category: Shares Reserved Valid Bids Received Shares Validly Tendered Response (in times) Reserved Category (Small Shareholders): 97,342 8,862 2,00,518 2.06 General Category (All Other Eligible Shareholders): 3,72,658 995 24,56,966 6.59 Total: 4,70,000 9,857 26,57,484 5.65

Communication of acceptance or rejection was sent by the Registrar to eligible shareholders on May 14, 2026. Settlement of all valid bids was completed by the Clearing Corporation on May 14, 2026, with direct funds payout made to eligible shareholders. Unaccepted dematerialised equity shares were returned to respective Seller Members or Custodians on the same date.

Shareholding Pattern: Pre and Post Buyback

The buyback has resulted in a notable shift in the shareholding pattern. Promoters and persons acting in concert held 1,30,65,352 shares (61.90%) before the buyback, with their percentage shareholding rising to 63.31% post-extinguishment as the total share count reduces. The table below summarises the pre and post-buyback shareholding pattern as on the Record Date of April 24, 2026:

Shareholder Category: Pre-Buyback Shares Pre-Buyback % Post-Buyback Shares* Post-Buyback % Promoters and persons acting in concert: 1,30,65,352 61.90 1,30,65,352 63.31 Foreign Investors (OCBs/FIIs/NRIs/Non-residents/Non-domestic companies): 4,66,484 2.21 75,70,877 36.69 Indian Financial Institutions/Banks/Mutual Funds/Govt. Companies: 24,52,250 11.62 — — Public including other Bodies Corporate: 51,22,143 24.27 — — Total: 2,11,06,229 100.00 2,06,36,229 100.00

*Post Extinguishment of 4,70,000 Equity Shares

Major Shareholders Participating in the Buyback

The following eligible shareholders had equity shares exceeding 1% of the total equity shares accepted under the buyback:

Sr. No.: Shareholder Name: Shares Accepted: % of Total Buyback: % of Post-Buyback Capital: 1: ICICI Prudential Smallcap Fund 1,44,516 30.75 0.70 2: Perpetuity Health to Wealth (H2W) Rising Fund 34,160 7.27 0.17 3: Ajay Kumar Aggarwal 24,857 5.29 0.12 4: UTI-Healthcare Fund 18,461 3.93 0.09 5: Vaikarya Change India Fund 7,469 1.59 0.04 6: Micro Strategies Fund 7,406 1.58 0.04 7: Legends Global Opportunities (Singapore) Pte. Ltd. 6,832 1.45 0.03 8: Rakesh Kumar Sharma 4,842 1.03 0.02

Certification and Regulatory Compliance

The Certificate of Extinguishment dated May 18, 2026 was duly certified and verified by MUFG Intime India Private Limited (Registrar to the Buyback), M/s. Sandeep Joshi & Associates, Company Secretaries (Secretarial Auditor), and the Company, in compliance with Regulation 11 of the SEBI (Buy-back of Securities) Regulations, 2018. The extinguishment was carried out in accordance with the provisions of the Companies Act, 2013, SEBI (Depositories and Participants) Regulations, 2018, and other applicable provisions. Fintellectual Corporate Advisors Private Limited, based in Noida, Uttar Pradesh (SEBI Registration No.: INM000012944), served as the Manager to the Buyback. The announcement was signed by Managing Director Hitesh Windlass, Joint Managing Director Manoj Kumar Windlass, and Company Secretary and Compliance Officer Ananta Narayan Panda.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.